corpus.blog
41554 blogs · 4,417,066 posts Claim your blog
Record · corpus.blog/posts/01a0be06-6eb4-7170-a5b6-820c8f519263

The road ahead: 2025 (part 1)

scienceofparkinsons.com · published 1 January 2025

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at scienceofparkinsons.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
Links from this post
494
Words captured
16,907

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://scienceofparkinsons.com/wp-content/uploads/2016/10/road-e1546372441841.jpg
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2023/03/future.jpg
scienceofparkinsons.com
https://www.inc.com/business-insider/21-new-jobs-future-robots-automation.html
inc.com
https://scienceofparkinsons.com/2017/06/26/the-other-anniversary-20-years-of-alpha-synuclein/
scienceofparkinsons.com
https://www.ncbi.nlm.nih.gov/pubmed/9197268
ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2023/03/synuclein.jpg
scienceofparkinsons.com
https://www.ncbi.nlm.nih.gov/pubmed/9278044
ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/gwas-pd-nalls-2019.webp
scienceofparkinsons.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC8422160/
pmc.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2023/01/er8drm0ucageccd-1.jpg
scienceofparkinsons.com
https://twitter.com/johncutlefish/status/1350830723612098561
twitter.com
https://scienceofparkinsons.com/wp-content/uploads/2023/01/postmortem-brain.png
scienceofparkinsons.com
https://wellcomecollection.org/articles/the-anatomy-of-a-brain-dissection
wellcomecollection.org
https://scienceofparkinsons.com/wp-content/uploads/2023/01/advantages-1024x683-1.jpg
scienceofparkinsons.com
https://oakwoodlabs.com/what-are-the-5-stages-of-drug-development/
oakwoodlabs.com
https://scienceofparkinsons.com/wp-content/uploads/2023/01/clinical_trials_process_0.png
scienceofparkinsons.com
https://cancergrace.org/post/searching-clinical-trials-we-want-help
cancergrace.org
https://t.co/MXVxXMBq9W
t.co
https://www.proteinatlas.org/humanproteome/brain/human+brain
proteinatlas.org
https://scienceofparkinsons.com/wp-content/uploads/2015/12/fig2_v1c.png
scienceofparkinsons.com
http://www.curedementia.link/lewis-body-disease/
curedementia.link
https://scienceofparkinsons.com/wp-content/uploads/2017/05/lewy_neurites_alpha_synuclein1.jpg
scienceofparkinsons.com
https://commons.wikimedia.org/wiki/File:Lewy_neurites_alpha_synuclein.jpg
commons.wikimedia.org
https://pmc.ncbi.nlm.nih.gov/articles/PMC5040622/
pmc.ncbi.nlm.nih.gov
https://pmc.ncbi.nlm.nih.gov/articles/PMC5054685/
pmc.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2015/12/mechanism-of-syunuclein-propagation-and-fibrillization.jpg
scienceofparkinsons.com
http://www.nature.com/nrn/journal/v14/n1/full/nrn3406.html
nature.com
https://www.astrazeneca.com/what-science-can-do/yte.html
astrazeneca.com
https://scienceofparkinsons.com/wp-content/uploads/2018/01/03_supraanigen_platform.jpg
scienceofparkinsons.com
https://www.acimmune.com/en/technology-platforms/
acimmune.com
https://www.roche.com/
roche.com
https://www.prothena.com/
prothena.com
https://scienceofparkinsons.com/wp-content/uploads/2018/05/pasadena_1900x600.jpg
scienceofparkinsons.com
https://scienceofparkinsons.com/2020/09/16/pasadena-2/
scienceofparkinsons.com
https://www.vai.org/event/grand-challenges-in-parkinsons-disease/
vai.org
https://www.ppmi-info.org/
ppmi-info.org
https://scienceofparkinsons.com/wp-content/uploads/2024/10/pasi-ppmi.png
scienceofparkinsons.com
https://www.clinicaltrials.gov/ct2/show/NCT04777331
clinicaltrials.gov
https://www.roche.com/media/releases/med-cor-2024-12-19
roche.com
https://www.thesparkstudy.com/
thesparkstudy.com
https://www.biogen.com/en_us/home.html
biogen.com
https://scienceofparkinsons.com/wp-content/uploads/2018/04/download.png
scienceofparkinsons.com
https://scienceofparkinsons.com/2018/04/25/biib054/
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT03318523
clinicaltrials.gov
https://scienceofparkinsons.com/wp-content/uploads/2018/08/biogen-svg.png
scienceofparkinsons.com
https://investors.biogen.com/static-files/289632ca-1022-4344-8bd3-0205a2e1246f
investors.biogen.com
https://www.nejm.org/doi/full/10.1056/NEJMoa2203395
nejm.org
http://www.takeda.com/who-we-are/company-information/worldwide-offices/takeda-pharmaceutical-company-limited/
takeda.com
https://www.astrazeneca.com/
astrazeneca.com
https://clinicaltrials.gov/ct2/show/NCT03272165
clinicaltrials.gov
https://www.sciencedirect.com/science/article/pii/S0969996119302505
sciencedirect.com
https://clinicaltrials.gov/study/NCT05526391
clinicaltrials.gov
https://www.alzforum.org/therapeutics/tak-341
alzforum.org
https://scienceofparkinsons.com/wp-content/uploads/2025/01/takeda-pharmaceutical.jpg
scienceofparkinsons.com
https://www.lundbeck.com/uk
lundbeck.com
http://www.genmab.com/
genmab.com
https://clinicaltrials.gov/ct2/show/NCT03611569
clinicaltrials.gov
https://www.clinicaltrials.gov/ct2/show/NCT05104476
clinicaltrials.gov
https://pharmaphorum.com/news/lundbeck-study-knocks-confidence-alpha-syn-cns-target
pharmaphorum.com
https://www.lundbeck.com/content/dam/lundbeck-com/masters/global-site/global-site/investors/2024/amulet-update/Lu%20AF82422%20phase%20II%20PoC%20read-out%20(AMULET
lundbeck.com
https://mb.cision.com/Main/18215/3940069/2643599.pdf
mb.cision.com
https://scienceofparkinsons.com/wp-content/uploads/2018/11/1200px-lundbeck-svg.png
scienceofparkinsons.com
https://www.abbvie.com/
abbvie.com
https://clinicaltrials.gov/ct2/show/NCT04127695
clinicaltrials.gov
https://www.bioarctic.se/en/ban0805-parkinsons-disease-2498/
bioarctic.se
https://www.sciencedirect.com/science/article/pii/S0969996121002928
sciencedirect.com
https://www.bioarctic.se/en/abbvie-terminates-collaboration-with-bioarctic-on-alpha-synuclein-portfolio/
bioarctic.se
https://www.bioarctic.se/en/full-results-of-lecanemab-phase-3-confirmatory-clarity-ad-study-for-early-alzheimers-disease-published-in-the-new-england-journal-of-medicine/
bioarctic.se
https://scienceofparkinsons.com/wp-content/uploads/2017/12/bioarctic.png
scienceofparkinsons.com
https://www.novartis.co.uk/
novartis.co.uk
https://www.ucb.com/
ucb.com
https://clinicaltrials.gov/ct2/show/NCT04651153
clinicaltrials.gov
https://www.pharmaceutical-technology.com/data-insights/ucb-7853-ucb-parkinson-s-disease-likelihood-of-approval/?cf-view&cf-closed
pharmaceutical-technology.com
https://scienceofparkinsons.com/wp-content/uploads/2021/12/ucbnovartis-e1638533682352.jpg
scienceofparkinsons.com
https://www.sanofi.com/
sanofi.com
https://www.ablbio.com/
ablbio.com
https://www.cell.com/cell-chemical-biology/abstract/S2451-9456(23
cell.com
https://www.nature.com/articles/d43747-020-00409-5
nature.com
https://m.theinvestor.co.kr/view.php?ud=20221214000156
m.theinvestor.co.kr
https://www.koreabiomed.com/news/articleView.html?idxno=25518
koreabiomed.com
https://scienceofparkinsons.com/wp-content/uploads/2018/12/Sanofi-logo-1_0-e1544894968104.jpg
scienceofparkinsons.com
https://www.denalitherapeutics.com/pipeline
denalitherapeutics.com
https://adisinsight.springer.com/drugs/800055087
adisinsight.springer.com
https://scineuro.com/
scineuro.com
https://www.bioworld.com/articles/506151-scineuro-licenses-alpha-synuclein-targeted-antibodies-from-lilly-for-greater-china?v=preview
bioworld.com
https://promisneurosciences.com/
promisneurosciences.com
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496384/
ncbi.nlm.nih.gov
http://cognyxx.com/
cognyxx.com
https://www.acimmune.com/
acimmune.com
https://ir.acimmune.com/static-files/4518fbf1-cef3-46b3-9492-3c571c75849c
ir.acimmune.com
http://icbii.com/
icbii.com
https://adisinsight.springer.com/drugs/800045866
adisinsight.springer.com
https://alligatorbioscience.se/en/
alligatorbioscience.se
https://www.bioarctic.se/en/
bioarctic.se
https://alligatorbioscience.se/en/alligator-bioscience-and-bioarctic-enter-into-research-agreement-in-the-neurodegenerative-field/
alligatorbioscience.se
https://www.syngletherapeutics.com/geen-categorie/syngle-tx-successfully-completes-proof-of-concept-in-parkinsons-animal-model/
syngletherapeutics.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/syngle-therapeutics.webp
scienceofparkinsons.com
http://www.affiris.com/
affiris.com
https://www.alzforum.org/therapeutics/aci-7104056
alzforum.org
https://doi.org/10.1016/S1474-4422(20
doi.org
https://scienceofparkinsons.com/2020/06/20/vaccine/
scienceofparkinsons.com
https://scienceofparkinsons.com/2021/07/30/ac-immune/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2019/12/ac_immune_logo-e1575831375593.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/study/NCT06015841
clinicaltrials.gov
https://www.vaxxinity.com/
vaxxinity.com
https://scienceofparkinsons.com/wp-content/uploads/2021/01/vaxxinity.png
scienceofparkinsons.com
https://www.nature.com/articles/s41591-024-03101-8
nature.com
https://ir.vaxxinity.com/static-files/6aac54a7-4629-4384-942d-5bb3d0e4de47
ir.vaxxinity.com
https://clinicaltrials.gov/study/NCT05634876
clinicaltrials.gov
https://pmc.ncbi.nlm.nih.gov/articles/PMC11638298/
pmc.ncbi.nlm.nih.gov
http://capotherapeutics.com/
capotherapeutics.com
https://www.nuravax.com/
nuravax.com
https://www.prnewswire.com/news-releases/novel-preventive-vaccine-for-parkinsons-disease-would-move-into-human-trials-301457688.html
prnewswire.com
https://www.annovisbio.com/
annovisbio.com
https://scienceofparkinsons.com/wp-content/uploads/2020/01/annovis.png
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2022/01/g639041.jpg
scienceofparkinsons.com
https://www.sec.gov/Archives/edgar/data/1477845/000104746919003982/a2239177zs-1.htm
sec.gov
https://clinicaltrials.gov/study/NCT05686044
clinicaltrials.gov
https://www.annovisbio.com/press-release/annovis-bio-announces-statistically-significant-phase-ii-iii-data-in-patients-with-early-alzheimers-disease
annovisbio.com
https://www.ucb.com/stories-media/Press-Releases/article/UCB-Announces-Global-Partnership-to-Bring-Disease-Modifying-Therapies-to-People-Living-with-Parkinson-s-Disease
ucb.com
https://www.neuropore.com/
neuropore.com
https://clinicaltrials.gov/ct2/show/NCT04658186
clinicaltrials.gov
https://www.ucb.com/newsroom/press-releases/article/findings-from-minzasolmin-proof-of-concept-orchestra-study-shape-next-steps-in-ucb-parkinson-s-research-program
ucb.com
http://www.modag.net/index.php/en/
modag.net
https://scienceofparkinsons.com/wp-content/uploads/2019/07/modaglogo-e1562251242209.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT04208152
clinicaltrials.gov
https://www.businesswire.com/news/home/20200805005393/en/MODAG-Successfully-Completes-Phase-1-Study-of-their-Lead-Candidate-Anle138b-and-Receives-Additional-USD-1.4-Million-from-Michael-J.-Fox-Foundation
businesswire.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC9065877/
pmc.ncbi.nlm.nih.gov
https://www.businesswire.com/news/home/20201223005095/en/MODAG-Initiates-First-in-Patient-Phase-1b-Trial-for-Anle138b-in-Parkinson%C2%B4s-Disease
businesswire.com
https://clinicaltrials.gov/ct2/show/NCT04685265
clinicaltrials.gov
https://www.tevapharm.com/
tevapharm.com
https://scienceofparkinsons.com/2021/10/27/tevamodag/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2021/10/teva-modag-e1635628542935.jpg
scienceofparkinsons.com
https://ediss.uni-goettingen.de/handle/21.11130/00-1735-0000-0005-1519-8
ediss.uni-goettingen.de
https://topas-msa-study.com/
topas-msa-study.com
https://www.alzforum.org/therapeutics/emrusolmin
alzforum.org
https://enterininc.com/
enterininc.com
https://scienceofparkinsons.com/wp-content/uploads/2017/09/enterine.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT03047629
clinicaltrials.gov
https://www.sciencedirect.com/science/article/pii/S2590112519300015
sciencedirect.com
https://menafn.com/1098933004/Enterins-RASMET-Study-Published
menafn.com
https://clinicaltrials.gov/ct2/show/NCT03781791
clinicaltrials.gov
https://www.acpjournals.org/doi/10.7326/M22-1438
acpjournals.org
https://scienceofparkinsons.com/2022/02/08/enterin/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2022/01/enterin1.jpg
scienceofparkinsons.com
https://enterininc.com/news/
enterininc.com
https://scienceofparkinsons.com/wp-content/uploads/2022/01/enterin2.jpg
scienceofparkinsons.com
https://www.clinicaltrials.gov/ct2/show/NCT03938922
clinicaltrials.gov
https://alteritytherapeutics.com/
alteritytherapeutics.com
https://alteritytherapeutics.com/investor-centre/news/2024/12/04/alterity-therapeutics-completes-last-patient-visit-in-ath434-201-phase-2-clinical-trial-in-early-stage-multiple-system-atrophy/
alteritytherapeutics.com
https://scienceofparkinsons.com/wp-content/uploads/2020/01/alterity-e1578613514265.jpg
scienceofparkinsons.com
http://mtherapharma.com/index.php
mtherapharma.com
https://www.sciencedirect.com/science/article/pii/S0753332222010265
sciencedirect.com
http://mtherapharma.com/engsub/years.php
mtherapharma.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/mthera.png
scienceofparkinsons.com
https://www.greenvalleypharma.com/en
greenvalleypharma.com
https://pubmed.ncbi.nlm.nih.gov/32020555/
pubmed.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/green-valley.png
scienceofparkinsons.com
https://www.greenvalleypharma.com/En/Index/pageView/catid/82/id/261.html
greenvalleypharma.com
https://clinicaltrials.gov/search?term=GV%E2%80%90971
clinicaltrials.gov
https://pharmakure.com/
pharmakure.com
https://pharmakure.com/pk081/
pharmakure.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/pharmakure.png
scienceofparkinsons.com
https://scienceofparkinsons.com/2021/12/06/ucb-novartis/
scienceofparkinsons.com
https://www.ucl.ac.uk/comprehensive-clinical-trials-unit/research-projects/2021/nov/adept-pd
ucl.ac.uk
https://scienceofparkinsons.com/wp-content/uploads/2021/08/adept-pd.jpg
scienceofparkinsons.com
https://www.ucl.ac.uk/comprehensive-clinical-trials-unit/research-projects/2022/jan/adept-pd
ucl.ac.uk
https://priavoid.com/
priavoid.com
https://www.remynd.com/
remynd.com
https://www.remynd.com/about-us/news/remynds-parkinsons-disease-drug-discovery-program-reaches-breakthrough
remynd.com
https://www.axialtx.com/
axialtx.com
https://delta.larvol.com/Products/?ProductId=7eb9c64f-24ad-48ad-84b8-bf85932542fd
delta.larvol.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC7012599/
pmc.ncbi.nlm.nih.gov
https://nitrasetx.com/
nitrasetx.com
https://nitrasetx.com/wp-content/uploads/2024/03/ADPD-2024-presentation_Final.pdf
nitrasetx.com
https://wavebreaktx.com/
wavebreaktx.com
https://wavebreaktx.com/wavebreak-presents-new-preclinical-data-at-ad-pd-2024-demonstrating-efficacy-of-oral-clinical-candidate-wtx-607-in-preventing-formation-of-toxic-%ce%b1-synuclein-oligomers-and-aggregates-with-disease/
wavebreaktx.com
http://gismotherapeutics.com/
gismotherapeutics.com
http://gismotherapeutics.com/science/
gismotherapeutics.com
https://www.prevailtherapeutics.com/
prevailtherapeutics.com
https://www.prevailtherapeutics.com/category/press-releases/
prevailtherapeutics.com
https://seelostherapeutics.com/
seelostherapeutics.com
https://adisinsight.springer.com/drugs/800055223
adisinsight.springer.com
https://seelostherapeutics.com/sls-007/
seelostherapeutics.com
https://ir.ionispharma.com/
ir.ionispharma.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC8021121/
pmc.ncbi.nlm.nih.gov
https://www.nature.com/articles/s41598-019-43772-9
nature.com
http://arvinas.com/
arvinas.com
https://www.arvinas.com/research-and-development/pipeline/
arvinas.com
http://c4therapeutics.com/
c4therapeutics.com
https://www.biogen.com/
biogen.com
https://ir.c4therapeutics.com/news-releases/news-release-details/biogen-and-c4-therapeutics-enter-strategic-collaboration
ir.c4therapeutics.com
https://www.primarypeptides.com/pipeline.htm
primarypeptides.com
https://www.lilly.co.uk/
lilly.co.uk
https://scienceofparkinsons.com/wp-content/uploads/2020/12/lillyprevail-e1609094536821.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/study/NCT06565195
clinicaltrials.gov
https://www.mdsabstracts.org/abstract/first-in-human-single-and-multiple-ascending-dose-trial-design-of-ly3962681-a-novel-intrathecally-delivered-sirna-targeting-%CE%B1-synuclein-mrna-for-the-treatment-of-patients-with-parkinson/
mdsabstracts.org
https://scienceofparkinsons.com/wp-content/uploads/2025/01/regain-therapeutics.png
scienceofparkinsons.com
https://med.uc.edu/landing-pages/profile/index/pubs/espayaj
med.uc.edu
https://pmc.ncbi.nlm.nih.gov/articles/PMC11352499/
pmc.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2017/07/maxresdefault1.jpg
scienceofparkinsons.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC11492021/
pmc.ncbi.nlm.nih.gov
https://www.denalitherapeutics.com/
denalitherapeutics.com
https://scienceofparkinsons.com/wp-content/uploads/2017/12/denali-therapeutics.jpg
scienceofparkinsons.com
https://scienceofparkinsons.com/2021/05/27/denali-3/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2021/05/dnli-rabs-e1622318586998.png
scienceofparkinsons.com
https://www.denalitherapeutics.com/sites/default/files/2021-05/2021-05-24%20DNLI%20Corp%20Deck.pdf
denalitherapeutics.com
https://clinicaltrials.gov/study/NCT05418673
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT05348785
clinicaltrials.gov
https://investors.biogen.com/news-releases/news-release-details/statement-biogen-provides-update-parkinsons-disease-clinical
investors.biogen.com
https://clinicaltrials.gov/study/NCT06602193
clinicaltrials.gov
https://investors.denalitherapeutics.com/news-releases/news-release-details/denali-therapeutics-announces-first-participant-dosed-phase-2a
investors.denalitherapeutics.com
https://scienceofparkinsons.com/wp-content/uploads/2019/05/1920px-ionis_pharmaceuticals.svg_.png
scienceofparkinsons.com
https://scienceofparkinsons.com/2019/06/14/antisense/
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT03976349
clinicaltrials.gov
https://neuron23.com/
neuron23.com
https://www.origenis.de/
origenis.de
https://www.kleinerperkins.com/
kleinerperkins.com
https://www.origenis.de/post/origenis-founds-biotech-neuron23-in-silicon-valley-together-with-star-investor-kleiner-perkins
origenis.de
https://neuron23.com/neuron23-announces-first-in-human-dose-in-phase-1-clinical-trial-of-its-best-in-class-brain-penetrant-lrrk2-inhibitor-for-parkinsons-disease/
neuron23.com
https://www.clinicaltrials.gov/study/NCT05755191
clinicaltrials.gov
https://scienceofparkinsons.com/wp-content/uploads/2022/04/neuron23.png
scienceofparkinsons.com
https://www.clinicaltrials.gov/study/NCT06680830
clinicaltrials.gov
https://servier.com/en/
servier.com
https://www.oncodesign.com/en/
oncodesign.com
https://servier.com/en/newsroom/parkinson-exercises-exclusive-licensing-option-collaborative-program-opm/
servier.com
https://www.oncodesign.com/wp-content/uploads/2024/01/PIPELINE-JANV-24-EN.png
oncodesign.com
https://scienceofparkinsons.com/wp-content/uploads/2024/12/oncodesign-precision-medicine-e1734953736515.jpg
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2023/01/opm-202-en-1.png
scienceofparkinsons.com
https://www.oncodesign.com/our-pipeline/opm-201/
oncodesign.com
http://www.chinadrugtrials.org.cn/clinicaltrials.searchlistdetail.dhtml?id=df0fe83c4ee6426080adaeb9627e0780
chinadrugtrials.org.cn
http://www.1stbio.com/
1stbio.com
https://scienceofparkinsons.com/wp-content/uploads/2020/01/1st-bio.png
scienceofparkinsons.com
https://clinicaltrials.gov/study/NCT05995782
clinicaltrials.gov
https://www.brenigther.com/
brenigther.com
https://biogenerationventures.com/en/
biogenerationventures.com
https://www.brenigther.com/publications/brenig-therapeutics-announces-the-initiation-of-first-in-human-clinical-trial-of-bt-267-a-best-in-class-lrrk2-inhibitor-for-parkinsons-disease
brenigther.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/brenigtx-e1735751139528.jpg
scienceofparkinsons.com
https://www.arvinas.com
arvinas.com
https://scienceofparkinsons.com/wp-content/uploads/2019/01/arvinas_large-e1546736845544.jpg
scienceofparkinsons.com
https://ir.arvinas.com/news-releases/news-release-details/arvinas-announces-first-human-dosing-arv-102-investigational
ir.arvinas.com
https://www.arvinas.com/wp-content/uploads/2024/07/Opportunity-for-Oral-PROTAC%C2%AE-Degrader-Molecules-to-Selectively-Clear-Proteins-that-Cause-Neurodegenerative-Diseases-v2.pdf
arvinas.com
https://scienceofparkinsons.com/wp-content/uploads/2019/12/800px-merck_logo.svg_.png
scienceofparkinsons.com
https://www.merck.com/
merck.com
https://pubmed.ncbi.nlm.nih.gov/37861679/
pubmed.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/37916535/
pubmed.ncbi.nlm.nih.gov
https://www.gsk.com/en-gb/home/
gsk.com
https://www.slas-discovery.org/article/S2472-5552(22
slas-discovery.org
https://www.23andme.com/en-gb/
23andme.com
https://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines/
gsk.com
https://scienceofparkinsons.com/wp-content/uploads/2019/01/gsk-e1546902677140.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT03782753
clinicaltrials.gov
https://vesaliustx.com/
vesaliustx.com
https://www.prnewswire.com/news-releases/vesalius-announces-multi-target-strategic-alliance-with-gsk-to-develop-breakthrough-treatments-for-people-afflicted-with-parkinsons-disease-302301349.html?tc=eml_cleartime
prnewswire.com
https://www.abbvie.co.uk/
abbvie.co.uk
https://news.abbvie.com/2024-08-01-AbbVie-Completes-Acquisition-of-Cerevel-Therapeutics
news.abbvie.com
https://www.sealrocktx.com/
sealrocktx.com
https://www.sealrocktx.com/science.html
sealrocktx.com
https://www.brickellbio.com
brickellbio.com
https://www.lead-discovery.de/
lead-discovery.de
https://www.lead-discovery.de/wp-content/uploads/2020/02/news_89f662c6ab2a9eed4b008d97ed5afa70_0_en.pdf
lead-discovery.de
https://haliatx.com/
haliatx.com
https://haliatx.com/pipeline/
haliatx.com
https://scineuro.com/scineuro-pharmaceuticals-to-present-preclinical-efficacy-and-safety-data-on-snp614-a-novel-antisense-oligonucleotide-directed-to-lrrk2-at-the-2024-international-congress-of-parkinsons-disea/
scineuro.com
https://shapetx.com/
shapetx.com
https://www.globenewswire.com/news-release/2021/08/24/2285515/0/en/Shape-Therapeutics-enters-into-a-strategic-research-collaboration-with-Roche-to-advance-breakthrough-AAV-based-RNA-editing-technology-for-neuroscience-and-rare-disease-indications.html
globenewswire.com
https://www.businesswire.com/news/home/20210111005418/en/Shape-Therapeutics-to-Highlight-RNA-Editing-Technology-Platform-Advancements-in-Parkinson%E2%80%99s-Disease-and-the-Identification-of-Novel-CNS-targeting-AAV-Variants-at-the-J.P.-Morgan-39th-Annual-Healthcare-Conference
businesswire.com
https://www.korrobio.com/
korrobio.com
https://www.korrobio.com/pipeline/
korrobio.com
https://www.michaeljfox.org/
michaeljfox.org
https://parkinsonsroadmap.org/
parkinsonsroadmap.org
https://scienceofparkinsons.com/wp-content/uploads/2023/08/asap_mjff_logo-e1706201037640.png
scienceofparkinsons.com
https://scienceofparkinsons.com/2019/12/25/lrrk-3/
scienceofparkinsons.com
https://www.michaeljfox.org/grant/ppm1h-activators-treatment-parkinsons-disease
michaeljfox.org
https://www.annualreviews.org/docserver/fulltext/biochem/93/1/annurev-biochem-030122-051144.pdf?expires=1735757277&id=id&accname=guest&checksum=6E899362A8E93A59193434EF3ED3BDE6
annualreviews.org
https://www.gaucherdisease.org/about-gaucher-disease/what-is/
gaucherdisease.org
Just a lysosomal enzyme… Read at the source ↗
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2019/06/prevail-gba.jpg
scienceofparkinsons.com
https://prezi.com/zdhyx_eynman/lysosomes/
prezi.com
https://scienceofparkinsons.com/2021/02/08/limp2/
scienceofparkinsons.com
https://skinflint.co.uk/ambroxol-ratiopharm-30mg-cough-solver-tablets-a1562027.html
skinflint.co.uk
https://scienceofparkinsons.com/2020/01/14/ambroxol/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2021/01/m_noi190109f2-e1610410934837.png
scienceofparkinsons.com
https://jamanetwork.com/journals/jamaneurology/fullarticle/2758317
jamanetwork.com
https://clinicaltrials.gov/study/NCT05778617
clinicaltrials.gov
https://pdfrontline.com/en
pdfrontline.com
http://www.vai.org/press-release-2-22-2016/
vai.org
https://www.parkinsons.org.uk/
parkinsons.org.uk
https://clinicaltrials.gov/study/NCT05830396
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT05287503
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT04588285
clinicaltrials.gov
https://www.garvan.org.au/research/collaboration/australian-parkinsons-mission
garvan.org.au
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=385904
anzctr.org.au
https://clinicaltrials.gov/ct2/show/NCT02914366
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT02914366
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT04405596
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT06193421
clinicaltrials.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/agyany-pharma-e1735773923493.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/study/NCT04388969
clinicaltrials.gov
https://www.bial.com/com/
bial.com
https://scienceofparkinsons.com/wp-content/uploads/2022/01/bial-biotech-logo-002.gif
scienceofparkinsons.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC8451761/
pmc.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/37195859/
pubmed.ncbi.nlm.nih.gov
https://clinicaltrials.gov/study/NCT05819359
clinicaltrials.gov
https://www.bial.com/com/media/news-1/posts/bial-rd-announces-first-patient-dosed-in-its-phase-2-clinical-trial-of-bia-28-6156/
bial.com
https://www.morningstar.com/news/pr-newswire/20250107ln83759/bial-announces-first-patient-out-in-its-phase-2-clinical-trial-of-bia-28-6156-a-novel-therapy-for-gba1-parkinsons-disease
morningstar.com
https://gaintherapeutics.com/
gaintherapeutics.com
https://scienceofparkinsons.com/wp-content/uploads/2020/12/gain.png
scienceofparkinsons.com
https://gaintherapeutics.com/newsroom/press-releases/press-releases-2024/gain-therapeutics-announces-positive-topline-results-from-the-phase-1-clinical-trial-of-gt-02287-a-novel-gcase-targeting-small-molecule-therapy-for-parkinsons-disease/
gaintherapeutics.com
https://gaintherapeutics.com/wp-content/uploads/2024/10/MDS2024_phase1.pdf
gaintherapeutics.com
https://gaintherapeutics.com/newsroom/press-releases/press-releases-2024/gain-therapeutics-initiates-phase-1b-clinical-trial-of-lead-candidate-gt-02287-in-people-with-gba1-and-idiopathic-parkinsons-disease/
gaintherapeutics.com
https://clinicaltrials.gov/study/NCT06732180
clinicaltrials.gov
https://www.vanquabio.com/
vanquabio.com
https://scienceofparkinsons.com/wp-content/uploads/2021/09/vanqua-logo-vertical-stack.png
scienceofparkinsons.com
https://www.vanquabio.com/vanqua-bio-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-vq-101-its-small-molecule-gcase-activator-for-gba-parkinsons-disease-and-related-disorders/
vanquabio.com
https://www.vanquabio.com/vanqua-bio-announces-positive-interim-results-from-phase-1-clinical-trial-of-vq-101-an-orally-administered-brain-penetrant-allosteric-activator-of-gcase-for-the-treatment-of-gba-parkinsons/
vanquabio.com
https://scienceofparkinsons.com/2020/12/15/prevail-lilly/
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT04127578
clinicaltrials.gov
https://www.scribetx.com/
scribetx.com
https://www.biospace.com/lilly-s-prevail-doudna-s-scribe-partner-on-genetic-treatments-for-neuro-diseases
biospace.com
https://www.pharmaceutical-technology.com/analyst-comment/crispr-drug-licensing-deals/
pharmaceutical-technology.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/scribe_logo-e1735838590463.jpg
scienceofparkinsons.com
https://capsida.com/
capsida.com
https://capsida.com/strategic-collaboration-with-prevail/
capsida.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/capsida.jpg
scienceofparkinsons.com
https://scienceofparkinsons.com/2017/12/10/monkeys/
scienceofparkinsons.com
https://capsida.com/new-data-demonstrate-substantial-therapeutic-potential-of-capsidas-iv-gene-therapy-for-parkinsons-disease-associated-with-gba-mutations/
capsida.com
https://capsida.com/pipeline/
capsida.com
https://capsida.com/wp-content/uploads/Capsida-Non-Confidential-Corporate-Deck-120624.pdf
capsida.com
https://spurtherapeutics.com/
spurtherapeutics.com
https://www.globenewswire.com/news-release/2024/12/03/2990425/0/en/Spur-Therapeutics-Announces-Development-Candidate-in-Parkinson-s-Disease-Gene-Therapy-Program.html
globenewswire.com
https://www.globenewswire.com/news-release/2024/10/23/2967469/0/en/Spur-Therapeutics-Showcases-Positive-New-Data-from-Phase-1-2-GALILEO-1-Trial-of-FLT201-Its-Novel-Gene-Therapy-Candidate-for-Gaucher-Disease-in-Oral-Presentation-at-ESGCT-31st-Annua.html
globenewswire.com
https://www.voyagertherapeutics.com/
voyagertherapeutics.com
https://ir.voyagertherapeutics.com/news-releases/news-release-details/voyager-therapeutics-announces-selection-development-candidate-0
ir.voyagertherapeutics.com
https://coavetx.com/
coavetx.com
https://aperturagtx.com/
aperturagtx.com
https://www.science.org/doi/10.1126/science.adm8386
science.org
https://congruencetx.com/
congruencetx.com
https://www.prnewswire.com/news-releases/congruence-therapeutics-announces-poster-presentation-on-discovery-of-novel-gcase-correctors-for-parkinsons-disease-with-gba1-mutations-at-the-2024-international-congress-of-parkinsons-disease-and-movement-disorders-meeting-302261064.html
prnewswire.com
https://www.sharptx.com/priorities
sharptx.com
https://www.amgen.com/
amgen.com
https://neumoratx.com/
neumoratx.com
https://prnewswire.com/news-releases/amgen-and-neumora-therapeutics-announce-strategic-rd-collaboration-to-accelerate-novel-precision-therapies-for-brain-diseases-301394770.html
prnewswire.com
https://www.amicusrx.com/
amicusrx.com
https://ir.amicusrx.com/news-releases/news-release-details/amicus-therapeutics-presents-preclinical-studies-chaperone
ir.amicusrx.com
https://www.arkudatx.com/
arkudatx.com
https://www.michaeljfox.org/grant/compounds-enhance-activity-gcase-treatment-parkinsons-disease
michaeljfox.org
https://innovativemedicine.jnj.com/
innovativemedicine.jnj.com
https://www.biospace.com/arkuda-therapeutics-announces-option-and-asset-purchase-agreement
biospace.com
https://www.denalitherapeutics.com/home
denalitherapeutics.com
https://www.denalitherapeutics.com/sites/default/files/2023-07/Denali%20Therapeutics%20Corporate%20Deck%20-%20July%202023.pdf
denalitherapeutics.com
https://alector.com/pipeline/
alector.com
https://www.roche.com/stories/brain-shuttle-in-research-technologies
roche.com
https://pubmed.ncbi.nlm.nih.gov/37045813/
pubmed.ncbi.nlm.nih.gov
http://alectos.com/content/
alectos.com
https://alectos.com/alectos-content/index.php/2022/06/06/biogen-and-alectos-therapeutics-announce-license-and-collaboration-agreement-for-al01811-a-novel-gba2-inhibitor-for-the-potential-treatment-of-parkinsons-disease/
alectos.com
https://www.fiercebiotech.com/biotech/biogen-shoring-back-its-pipeline-bets-more-700m-alectos-preclinical-oral-parkinsons-med
fiercebiotech.com
https://scienceofparkinsons.com/wp-content/uploads/2025/01/alectos_logo_ai_h.png
scienceofparkinsons.com
https://www.sciencedirect.com/science/article/pii/S0022283622005599
sciencedirect.com
https://pubmed.ncbi.nlm.nih.gov/31097622/
pubmed.ncbi.nlm.nih.gov
https://www.businesswire.com/news/home/20220126005030/en/Caraway-Therapeutics-Receives-Third-Research-Grant-from-The-Michael-J.-Fox-Foundation-to-Continue-Advancement-of-TRPML1-Agonists-for-GBA-Parkinson%E2%80%99s-Disease
businesswire.com
https://www.bioworld.com/articles/696300-caraway-therapeutics-presents-new-mucolipin-activators?v=preview
bioworld.com
https://www.msd.com/news/msd-to-acquire-caraway-therapeutics-inc/
msd.com
https://www.lysoway.com/
lysoway.com
https://www.bioworld.com/articles/704085-lysoway-therapeutics-discloses-new-mucolipin-1-activators?v=preview
bioworld.com
https://www.casmatx.com/
casmatx.com
https://libratx.com/
libratx.com
https://www.michaeljfox.org/grant/testing-small-molecules-activate-removal-cellular-debris-treatment-parkinsons-disease
michaeljfox.org
https://www.bioworld.com/articles/714578-arkuda-therapeutics-reports-new-mucolipin-1-blockers?v=preview
bioworld.com
https://pubmed.ncbi.nlm.nih.gov/35750034/
pubmed.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/combinedartboard-1-4-1024x437-1.jpg
scienceofparkinsons.com
https://foldingathome.org/2022/04/07/understanding-druggable-states-in-a-protein-implicated-in-parkinsons-disease/
foldingathome.org
https://www.abbvie.com/cerevel.html
abbvie.com
https://www.nanion.de/news/tmem175-a-promising-therapeutic-target-for-parkinsons-disease/
nanion.de
https://www.lysoway.com/companynews/lysoway-therapeutics-has-received-a-research-grant-from-the-silverstein-foundation-to-investigate-the-therapeutic-potential-of-its-lysosomal-ion-channel-modulators-in-gba-deficient-parkinsons/
lysoway.com
https://synapse.patsnap.com/drug/c2341208dbbf417d9f00786c2c2dd3d1
synapse.patsnap.com
https://www.nanion.de/
nanion.de
https://www.cell.com/biophysj/abstract/S0006-3495(23
cell.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC10187700/
pmc.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/29628303/
pubmed.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/33562649/
pubmed.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/31434803/
pubmed.ncbi.nlm.nih.gov
https://teiturtrophics.com/
teiturtrophics.com
https://teiturtrophics.com/our-science/parkinsons-disease/
teiturtrophics.com
https://jnnp.bmj.com/content/95/Suppl_1/A149.1
jnnp.bmj.com
https://scienceofparkinsons.com/2021/06/14/gpnmb/
scienceofparkinsons.com
https://pubmed.ncbi.nlm.nih.gov/35981040/
pubmed.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/science.abk0637-fa-e1737194582445.jpg
scienceofparkinsons.com
https://www.science.org/doi/10.1126/science.abk0637
science.org
https://pubmed.ncbi.nlm.nih.gov/34464706/
pubmed.ncbi.nlm.nih.gov
https://docs.publicnow.com/viewDoc?filename=178289%5CEXT%5CFC8B18D10E234EE309DC63DC5D59E63021B32B00_3A64049A03FBD20EEC8182B6FAA3889775F10D13.PDF
docs.publicnow.com
https://www.gsk.com/en-gb/media/press-releases/gsk-and-alector-collaboration-in-immuno-neurology/
gsk.com
https://clinicaltrials.gov/study/NCT05262023
clinicaltrials.gov
https://www.vesperbio.com/
vesperbio.com
https://www.vesperbio.com/_files/ugd/61ce8f_a5904fc644f7426ea45e85ffb889b335.pdf
vesperbio.com
https://www.alzforum.org/news/conference-coverage/pumping-progranulin-scientists-show-new-efforts-get-it-done
alzforum.org
http://www.wormbook.org/chapters/www_autophagy/autophagy.html
wormbook.org
https://scienceofparkinsons.com/wp-content/uploads/2022/04/cell-organelles-mitochondria-1024x676-1.jpg
scienceofparkinsons.com
https://ohiostate.pressbooks.pub/vethisto/chapter/1-mitochondria/
ohiostate.pressbooks.pub
https://elifesciences.org/articles/23908
elifesciences.org
https://scienceofparkinsons.com/2020/09/24/paris/
scienceofparkinsons.com
https://www.ncbi.nlm.nih.gov/books/NBK1478/
ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2019/02/structure-of-ursodeoxycholic-acid-udca.jpeg
scienceofparkinsons.com
http://www.isrctn.com/ISRCTN73371260
isrctn.com
The UP Study results Read at the source ↗
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2023/06/upstudycadence.png
scienceofparkinsons.com
https://movementdisorders.onlinelibrary.wiley.com/doi/10.1002/mds.29450
movementdisorders.onlinelibrary.wiley.com
https://ejsactpd.com/
ejsactpd.com
https://scienceofparkinsons.com/2021/06/26/actpd/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2023/03/ejs-actpd.png
scienceofparkinsons.com
https://jnnp.bmj.com/content/95/Suppl_2/A44.3
jnnp.bmj.com
https://scienceofparkinsons.com/wp-content/uploads/2019/09/how-does-x-works-02-4-e1568844379360.png
scienceofparkinsons.com
https://pubmed.ncbi.nlm.nih.gov/31524631/
pubmed.ncbi.nlm.nih.gov
https://clinicaltrials.gov/ct2/show/NCT03905811
clinicaltrials.gov
https://scienceofparkinsons.com/2021/12/16/terazosin-2/
scienceofparkinsons.com
https://www.clinicaltrials.gov/ct2/show/NCT04551040
clinicaltrials.gov
https://www.medrxiv.org/content/10.1101/2024.05.22.24307622v1
medrxiv.org
https://scienceofparkinsons.com/wp-content/uploads/2017/04/mjfflogo.jpg
scienceofparkinsons.com
https://www.clinicaltrials.gov/ct2/show/NCT04760860
clinicaltrials.gov
https://neuro-sysmed.no/trials/no-park/
neuro-sysmed.no
https://scienceofparkinsons.com/2022/03/11/nad-2/
scienceofparkinsons.com
https://scienceofparkinsons.com/wp-content/uploads/2018/06/vitb3forms.png
scienceofparkinsons.com
https://clinicaltrials.gov/ct2/show/NCT03568968
clinicaltrials.gov
https://pubmed.ncbi.nlm.nih.gov/35235774/
pubmed.ncbi.nlm.nih.gov
https://pubmed.ncbi.nlm.nih.gov/38016950/
pubmed.ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2022/04/nadpark.jpg
scienceofparkinsons.com
https://www.cell.com/cell-metabolism/fulltext/S1550-4131(22
cell.com
https://clene.com/
clene.com
https://pubmed.ncbi.nlm.nih.gov/38087362/
pubmed.ncbi.nlm.nih.gov
https://invest.clene.com/static-files/c603c47c-c48b-400a-a644-cdeae3bdede9
invest.clene.com
https://scienceofparkinsons.com/wp-content/uploads/2019/11/clene-e1572570397556.jpg
scienceofparkinsons.com
https://www.fascinatetherapeutics.com/
fascinatetherapeutics.com
http://kainosmedicine.com/?lang=eng
kainosmedicine.com
https://scienceofparkinsons.com/wp-content/uploads/2021/12/fascinate-logo.png
scienceofparkinsons.com
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445238/
ncbi.nlm.nih.gov
https://clinicaltrials.gov/study/NCT05670782
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT05695378
clinicaltrials.gov
https://www.mitokinin.com/
mitokinin.com
https://news.abbvie.com/2023-10-05-AbbVie-Exercises-Exclusive-Right-to-Acquire-Mitokinin,-Further-Strengthening-Neuroscience-Pipeline
news.abbvie.com
https://scienceofparkinsons.com/wp-content/uploads/2020/01/mitokinin--e1578247713969.jpg
scienceofparkinsons.com
https://clinicaltrials.gov/study/NCT06414798
clinicaltrials.gov
https://clinicaltrials.gov/study/NCT06579300
clinicaltrials.gov
https://scienceofparkinsons.com/wp-content/uploads/2018/04/abbvie-logo.png
scienceofparkinsons.com
https://www.khondrion.com/
khondrion.com
https://www.ncbi.nlm.nih.gov/books/NBK532959/
ncbi.nlm.nih.gov
https://www.biospace.com/new-patents-granted-for-khondrion-s-mitochondrial-disease-lead-compound-kh176
biospace.com
https://stealthbt.com/
stealthbt.com
https://stealthbt.com/stealth-biotherapeutics-awarded-grant-from-the-michael-j-fox-foundation-to-support-development-of-sbt-272-in-parkinsons-disease/
stealthbt.com
https://www.mitorxtherapeutics.com/
mitorxtherapeutics.com
https://www.mitochonpharma.com/
mitochonpharma.com
https://www.mitochonpharma.com/science-technology/
mitochonpharma.com
https://www.nrgtherapeutics.com/home
nrgtherapeutics.com
https://www.nrgtherapeutics.com/news/18/51/NRG-Therapeutics-Selects-First-Development-Candidate-NRG5051-and-Secures-Grant-from-The-Michael-J.-Fox-Foundation-for-Development-of-mPTP-Inhibitors-to-Treat-Neurodegenerative-Diseases.html
nrgtherapeutics.com
https://www.lucytherapeutics.com/
lucytherapeutics.com
https://www.bioworld.com/articles/690598-lucy-therapeutics-validates-new-mitochondrial-based-therapeutic-approach-for-parkinsons-disease?v=preview
bioworld.com
https://www.businesswire.com/news/home/20240528977106/en/Lucy-Therapeutics-Secures-New-Funding-to-Advance-New-Alzheimer%E2%80%99s-and-Parkinson%E2%80%99s-Treatments
businesswire.com
https://revalesio.com/
revalesio.com
https://revalesio.com/pipeline/
revalesio.com
https://abliva.com/
abliva.com
https://abliva.com/wp-content/uploads/2024/09/Abliva_NonConf_July-2024.pdf
abliva.com
https://www.astellas.com/en/
astellas.com
https://pubmed.ncbi.nlm.nih.gov/34642949/
pubmed.ncbi.nlm.nih.gov
https://www.ashatherapeutics.com/pipeline
ashatherapeutics.com
https://www.ashatherapeutics.com/post/balancing-checkbooks
ashatherapeutics.com
https://capacitybio.com/
capacitybio.com
https://capacitybio.com/2023/03/capactiy-bio-closes-35m-financing-to-advance-mitophagy-platform/
capacitybio.com
https://www.pretzeltx.com/
pretzeltx.com
https://www.pretzeltx.com/pretzel-therapeutics-launches-with-72-5-million-series-a-financing-to-pioneer-mitochondrial-therapies/
pretzeltx.com
https://www.nysnobio.com/
nysnobio.com
https://www.nysnobio.com/news/nysnobio-awarded-mjff-grant-additional-funding
nysnobio.com
https://www.nysnobio.com/pipeline
nysnobio.com
https://progenra.com/
progenra.com
https://scienceofparkinsons.com/genetics-of-pd/
scienceofparkinsons.com
https://www.ncbi.nlm.nih.gov/pubmed/2166150
ncbi.nlm.nih.gov
https://www.ncbi.nlm.nih.gov/pubmed/9774100
ncbi.nlm.nih.gov
https://www.ncbi.nlm.nih.gov/pubmed/12210873
ncbi.nlm.nih.gov
https://scienceofparkinsons.com/wp-content/uploads/2025/01/f11.large_.jpg
scienceofparkinsons.com
https://www.life-science-alliance.org/content/3/8/e202000768
life-science-alliance.org
On a mitophagy MISSION Read at the source ↗
scienceofparkinsons.com
https://missiontherapeutics.com/
missiontherapeutics.com
https://pubmed.ncbi.nlm.nih.gov/37957154/
pubmed.ncbi.nlm.nih.gov
https://missiontherapeutics.com/mission-therapeutics-commences-landmark-trial-of-mtx325-a-potential-disease-modifying-treatment-for-parkinsons-disease/
missiontherapeutics.com
https://pubs.acs.org/doi/10.1021/jacs.0c04527
pubs.acs.org
https://scienceofparkinsons.com/wp-content/uploads/2018/05/mission_official_1.jpg
scienceofparkinsons.com
https://www.novonordisk.com/
novonordisk.com
https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=132653
novonordisk.com
https://scienceofparkinsons.com/2018/05/16/dubstop/
scienceofparkinsons.com
https://www.lundbeck.com/global
lundbeck.com
https://www.nature.com/articles/s41419-024-06439-6
nature.com
https://www.eisai.com/index.html
eisai.com
https://portlandpress.com/biochemj/article/478/23/4099/230002/Investigation-of-USP30-inhibition-to-enhance
portlandpress.com
https://vincerebio.com/
vincerebio.com
https://vincerebio.com/news
vincerebio.com
http://weknowyourdreams.com/road.html
weknowyourdreams.com